News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Barber Daniel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 223,500 rights
@ $0 |
|
| 05/05/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 223,500 rights
@ $0 |
|
| 03/09/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 447,000 shares
@ $0 |
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2020 |
4
| Barber Daniel (SVP-COO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $1.54, valued at
$169.4k
|
|
| 08/27/2019 |
4
| Barber Daniel (SVP-COO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $3.99, valued at
$8k
|
|
| 05/10/2019 |
4
| Barber Daniel (SVP-COO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.83, valued at
$241.5k
|
|
| 03/04/2019 |
4
| Barber Daniel (SVP-Chief Strategy/Dev Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 70,000 options to buy
@ $8.05, valued at
$563.5k
|
|
| 12/10/2018 |
4
| Barber Daniel (SVP-Chief Strategy/Dev Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $8, valued at
$8k
|
|
| 07/26/2018 |
4
| Barber Daniel (SVP-Chief Strategy/Dev Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 96,507 options to buy
@ $15, valued at
$1.4M
|
|
| 07/24/2018 |
3
| Barber Daniel (SVP-Chief Strategy/Dev Officer) has filed a Form 3 on Aquestive Therapeutics, Inc. |
|
|